GDF15 and breast carcinoma: Finally, we tested and confirmed the hypothesis that GDF15 itself plays a role in maintaining the DTP state by conducting GDF15 loss of function experiments, results of which led to a proof-of-concept study combining eribulin with an anti-GDF15 antibody to specifically inhibit the generation of DTP cells in both TNBC and luminal breast cancer cell lines.